Validation of a Preclinical Drug Screening Platform for Pharmacoresistant Epilepsy.

PubWeight™: 0.76‹?›

🔗 View Article (PMID 28303498)

Published in Neurochem Res on March 16, 2017

Authors

Melissa L Barker-Haliski1, Kristina Johnson2, Peggy Billingsley2, Jennifer Huff2, Laura J Handy2, Rizvana Khaleel2, Zhenmei Lu2, Matthew J Mau2, Timothy H Pruess2, Carlos Rueda2, Gerald Saunders2, Tristan K Underwood2, Fabiola Vanegas2, Misty D Smith2,3, Peter J West2,3, Karen S Wilcox2,3

Author Affiliations

1: Department of Pharmacy, University of Washington, Seattle, WA, 98195, USA. mhaliski@uw.edu.
2: Anticonvulsant Drug Development Program, University of Utah, Salt Lake City, UT, 84112, USA.
3: Department of Pharmacology & Toxicology, University of Utah, Salt Lake City, UT, 84112, USA.

Articles cited by this

Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol (1972) 16.34

A note on a simple apparatus for detecting neurological deficit in rats and mice. J Am Pharm Assoc Am Pharm Assoc (1957) 3.80

EXPERIMENTAL DETERMINATION OF THE ANTICONVULSANT PROPERTIES OF SOME PHENYL DERIVATIVES. Science (1937) 2.62

Pharmacological characterization of the 6 Hz psychomotor seizure model of partial epilepsy. Epilepsy Res (2001) 2.26

Adenosine: a potential mediator of seizure arrest and postictal refractoriness. Ann Neurol (1992) 2.11

Recurrent spontaneous motor seizures after repeated low-dose systemic treatment with kainate: assessment of a rat model of temporal lobe epilepsy. Epilepsy Res (1998) 1.96

Epilepsy and brain inflammation. Exp Neurol (2011) 1.67

Recurrent seizures and hippocampal sclerosis following intrahippocampal kainate injection in adult mice: electroencephalography, histopathology and synaptic reorganization similar to mesial temporal lobe epilepsy. Neuroscience (1999) 1.64

Diverse mechanisms of antiepileptic drugs in the development pipeline. Epilepsy Res (2006) 1.56

Preclinical development of antiepileptic drugs: past, present, and future directions. Epilepsia (2003) 1.53

Acetaminophen-induced liver injury in rats and mice: comparison of protein adducts, mitochondrial dysfunction, and oxidative stress in the mechanism of toxicity. Toxicol Appl Pharmacol (2012) 1.45

Evolution of hippocampal epileptic activity during the development of hippocampal sclerosis in a mouse model of temporal lobe epilepsy. Neuroscience (2002) 1.41

Interleukin-1β biosynthesis inhibition reduces acute seizures and drug resistant chronic epileptic activity in mice. Neurotherapeutics (2011) 1.36

Activation of hippocampal adenosine A3 receptors produces a desensitization of A1 receptor-mediated responses in rat hippocampus. J Neurosci (1997) 1.29

Use of chronic epilepsy models in antiepileptic drug discovery: the effect of topiramate on spontaneous motor seizures in rats with kainate-induced epilepsy. Epilepsia (2005) 1.28

Comparative anticonvulsant efficacy in the corneal kindled mouse model of partial epilepsy: Correlation with other seizure and epilepsy models. Epilepsy Res (2010) 1.25

Progress report on new antiepileptic drugs: a summary of the Eleventh Eilat Conference (EILAT XI). Epilepsy Res (2012) 1.24

Validation of corneally kindled mice: a sensitive screening model for partial epilepsy in man. Epilepsy Res (1998) 1.18

Hyperexcitability in combined entorhinal/hippocampal slices of adult rat after exposure to brain-derived neurotrophic factor. J Neurophysiol (1997) 1.15

Adenosine dysfunction in epilepsy. Glia (2011) 1.14

Anti-convulsive and anti-epileptic properties of brivaracetam (ucb 34714), a high-affinity ligand for the synaptic vesicle protein, SV2A. Br J Pharmacol (2008) 1.12

Animal models of intractable epilepsy. Prog Neurobiol (1997) 1.06

The cognitive impact of antiepileptic drugs. Ther Adv Neurol Disord (2011) 1.04

Morphogenetic effect of kainate on adult hippocampal neurons associated with a prolonged expression of brain-derived neurotrophic factor. Neuroscience (1995) 1.02

The early identification of anticonvulsant activity: role of the maximal electroshock and subcutaneous pentylenetetrazol seizure models. Ital J Neurol Sci (1995) 1.01

Correlation analysis between anticonvulsant ED50 values of antiepileptic drugs in mice and rats and their therapeutic doses and plasma levels. Epilepsy Behav (2004) 0.99

White coat adherence over the first year of therapy in pediatric epilepsy. J Pediatr (2012) 0.97

Should antidepressant drugs of the selective serotonin reuptake inhibitor family be tested as antiepileptic drugs? Epilepsy Behav (2013) 0.94

Structural sweet spot for A1 adenosine receptor activation by truncated (N)-methanocarba nucleosides: receptor docking and potent anticonvulsant activity. J Med Chem (2012) 0.92

A novel open-source drug-delivery system that allows for first-of-kind simulation of nonadherence to pharmacological interventions in animal disease models. J Neurosci Methods (2014) 0.87

Phenytoin- and carbamazepine-resistant spontaneous bursting in rat entorhinal cortex is blocked by retigabine in vitro. Epilepsy Res (2007) 0.87

Carbamazepine, but not valproate, displays pharmacoresistance in lamotrigine-resistant amygdala kindled rats. Epilepsy Res (2012) 0.84

Evaluating an etiologically relevant platform for therapy development for temporal lobe epilepsy: effects of carbamazepine and valproic acid on acute seizures and chronic behavioral comorbidities in the Theiler's murine encephalomyelitis virus mouse model. J Pharmacol Exp Ther (2015) 0.84

Neuronal Injury, Gliosis, and Glial Proliferation in Two Models of Temporal Lobe Epilepsy. J Neuropathol Exp Neurol (2016) 0.83

Low potency and limited efficacy of antiepileptic drugs in the mouse 6 Hz corneal kindling model. Epilepsy Res (2014) 0.82

The Biochemistry and Epigenetics of Epilepsy: Focus on Adenosine and Glycine. Front Mol Neurosci (2016) 0.82

Rapid loss of efficacy to the antiseizure drugs lamotrigine and carbamazepine: a novel experimental model of pharmacoresistant epilepsy. Epilepsia (2013) 0.81

Progress report on new antiepileptic drugs: A summary of the Thirteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIII). Epilepsia (2017) 0.81

Differential Effects of Antiepileptic Drugs on Focal Seizures in the Intrahippocampal Kainate Mouse Model of Mesial Temporal Lobe Epilepsy. CNS Neurosci Ther (2016) 0.81

Role(s) of the 5-HT2C receptor in the development of maximal dentate activation in the hippocampus of anesthetized rats. CNS Neurosci Ther (2014) 0.80

Overexpression of adenosine kinase in cortical astrocytes and focal neocortical epilepsy in mice. J Neurosurg (2013) 0.80

Fluoxetine enhances the anticonvulsant effects of conventional antiepileptic drugs in maximal electroshock seizures in mice. Pharmacol Rep (2006) 0.80

Acute cognitive impact of antiseizure drugs in naive rodents and corneal-kindled mice. Epilepsia (2016) 0.79

Acute treatment with minocycline, but not valproic acid, improves long-term behavioral outcomes in the Theiler's virus model of temporal lobe epilepsy. Epilepsia (2016) 0.79

Acetaminophen inhibits status epilepticus in cultured hippocampal neurons. Neuroreport (2011) 0.78

The impact of nonadherence to antiseizure drugs on seizure outcomes in an animal model of epilepsy. Epilepsia (2017) 0.78

Effects of fluoxetine on the anticonvulsant action of valproate and ethosuximide in mouse model of myoclonic convulsions. Ann Agric Environ Med (2012) 0.76

The role of the central serotonergic system in pilocarpine-induced seizures: receptor mechanisms. Neurosci Res (1989) 0.76